Amryt buys Aegerion via bankruptcy, adding sales to support R&D - Raglan Capital

Home
About Us
Selected Transactions
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Amryt buys Aegerion via bankruptcy, adding sales to support R&D

Home
2019
Amryt buys Aegerion via bankruptcy, adding sales to support R&D

Recent News

World’s first trial of deliberate coronavirus infection is approved
Scientists win approval to infect healthy volunteers with Covid for trial
Open Orphan gets final go-ahead for Covid-19 human trial
Covid-19: World’s first human challenge trials to start in UK
COVID-19: Volunteers to be exposed to virus in world-first study in UK
Open Orphan starts trials on nasal spray COVID-19 vaccines

Amryt buys Aegerion via bankruptcy, adding sales to support R&D

25th September 2019

https://otp.investis.com/clients/uk/amryt_pharmaceuticals_dac1/rns/regulatory-story.aspx?cid=1375&newsid=1218097

Prev
Next

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences